Heart Failure with Preserved Ejection Fraction After Surgical Aortic Valve Replacement: Prevalence, Prognosis and Predictors
Background/Objectives: Symptoms of heart failure (HF) often persist even after surgical aortic valve replacement (SAVR). However, the prevalence and prognostic significance of heart failure with preserved ejection fraction (HFpEF) after SAVR remain unclear. This study aimed to assess the prevalence, long-term outcomes, and predictors of HFpEF after successful SAVR. Methods: In total, 320 patients were prospectively followed with a comprehensive clinical and echocardiographic evaluation before and after SAVR. Results: One year after surgery, 63 patients (19.7%) met the diagnostic criteria for HFpEF, 36 patients (11.3%) had heart failure with (mildly) reduced ejection fraction (HF(m)rEF), and 221 patients (69.1%) were free from HF. Six-year follow-up revealed that HFpEF was associated with an increased risk of major adverse cardiovascular events (aHR 2.73, 95% CI 1.14–6.50; p = 0.024), primarily driven by HF-related hospitalizations (aHR 4.69, 95% CI 1.24–17.75; p = 0.023). Independent predictors of HFpEF were age (aOR 1.04, 95% CI 1.01–1.07; p < 0.001), body mass index (aOR 1.07, 95% CI 1.01–1.13; p = 0.018), smoking (aOR 2.33, 95% CI 1.20–4.53; p = 0.013), and a preoperative HFA-PEFF score ≥ 5 (aOR 2.76, 95% CI 1.41–5.42; p = 0.003). Conclusions: HFpEF was diagnosed in one out of five patients after successful SAVR and was associated with adverse long-term outcomes. Age, obesity, smoking, and HFA-PEFF scores were found to be independent predictors of postoperative HFpEF, which may guide perioperative risk stratification and early postoperative management.
Authors
- Christian Hengstenberg (ORCID: https://orcid.org/0000-0002-8284-2994)
- Philipp Emanuel Bartko (ORCID: https://orcid.org/0000-0001-9061-4839)
- Christina Binder (ORCID: https://orcid.org/0000-0001-6615-7105)
- Florian Frommlet (ORCID: https://orcid.org/0000-0003-4104-1768)
- Lore Schrutka (ORCID: https://orcid.org/0000-0002-2731-2667)
- Alfred A. Kocher (ORCID: https://orcid.org/0000-0002-2818-2227)
- Daniel Zimpfer (ORCID: https://orcid.org/0000-0002-2185-4895)
- Diana Bonderman (ORCID: https://orcid.org/0000-0002-6885-5924)
- Thomas Poschner (ORCID: https://orcid.org/0000-0003-0374-8375)
- Irene Marthe Lang (ORCID: https://orcid.org/0000-0003-0485-2692)
- Suriya Prausmüller (ORCID: https://orcid.org/0000-0002-6937-7979)
- Bea Goessinger (ORCID: https://orcid.org/0009-0009-9891-6466)
- Martin Andreas
- Jana A. Kiesenhofer
Institutions
- Medical University of Graz (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/jcm15229060
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00